Report overview
This report contains market size and forecasts of Cardiovascular Agents in global, including the following market information:
Global Cardiovascular Agents Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cardiovascular Agents Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cardiovascular Agents companies in 2021 (%)
The global Cardiovascular Agents market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antianginal Agents Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cardiovascular Agents include AstraZeneca, Pfizer, Novartis, Merck & Co, Bristol-Myers Squibb Company, Bayer, Sanofi, Boehringer Ingelheim and F. Hoffmann-La Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cardiovascular Agents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cardiovascular Agents Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiovascular Agents Market Segment Percentages, by Type, 2021 (%)
Antianginal Agents
Antiarrhythmic Agents
Inotropic Agents
Miscellaneous Cardiovascular Agents
Peripheral Vasodilators
Renin Inhibitors
Sclerosing Agents
Vasodilators
Global Cardiovascular Agents Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiovascular Agents Market Segment Percentages, by Application, 2021 (%)
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Global Cardiovascular Agents Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiovascular Agents Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cardiovascular Agents revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cardiovascular Agents revenues share in global market, 2021 (%)
Key companies Cardiovascular Agents sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cardiovascular Agents sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Pfizer
Novartis
Merck & Co
Bristol-Myers Squibb Company
Bayer
Sanofi
Boehringer Ingelheim
F. Hoffmann-La Roche
Abbott Laboratories
Gilead Sciences
Johnson & Johnson
Astellas Pharma
Eli Lilly and Company
Otsuka Holdings
Takeda Pharmaceutical Compan
